Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial

20252 citationsJournal Articlegold Open Access

Authors

Chao‐Yi Wu · Massachusetts General Hospital

William Reynolds · Massachusetts General Hospital

Isabel Abril · Massachusetts General Hospital

Alison J. McManus · Massachusetts General Hospital

Charles Brenner · City of Hope

Gabriel González-Irizarry · Massachusetts General Hospital

Leidys Gutiérrez-Martínez

Abstract

This work was supported by Niagen Bioscience, the MGH McCance Center for Brain Health, Lavine Brain Health Innovation Fund, MGH ECOR CDI Physician-Scientist Development Award, and the Alzheimer's Association (grant no. AARGD-23-114103).

Topics & Keywords

Calcium signaling and nucleotide metabolism Pharmacological Receptor Mechanisms and Effects Sirtuins and Resveratrol in Medicine

Publication Details

Published in: EClinicalMedicine

Volume 89, pp. 103633-103633

DOI: 10.1016/j.eclinm.2025.103633

Field-Weighted Citation Impact: 2.22

Command Palette

Effects of nicotinamide riboside on NAD+ levels, cognition, and symptom recovery in long-COVID: a randomized controlled trial

Authors

Abstract

Topics & Keywords

Publication Details